Home2024-10-08T07:15:58+00:00

THE MID-ATLANTIC BIO ANGELS® GROUP | MABA®

We invest in exciting life science companies worldwide

FOR ENTREPRENEURS

Apply for Funding

Review our Investment Criteria and Submit a Funding Application.

Pitch for Feedback

Too early for an investment? Apply to pitch to a panel of our investors for feedback.

From Our Blog

MABA Portfolio Company FEMSelect Unveils Positive Study Results for Its EnPlace Pelvic Organ Prolapse Repair System

In a recently published article in the International Journal of Gynecology & Obstetrics (IJGO), FEMSelect announced positive results for their EnPlace system. The research was presented during the 2023 International Urogynecology Association 48th Annual Meeting in The Hague, Netherlands. FEMSelect’s EnPlace system offers a new, minimally invasive technique for addressing pelvic organ prolapse without the need for extensive surgery or mesh. The study titled The EnPlace® sacrospinous ligament fixation—A novel minimally invasive transvaginal procedure for apical pelvic organ prolapse repair: Safety and short-term outcome results, focused on the safety and efficacy of the EnPlace system, a device cleared by [ Read more... ]

MABA is grateful for the support of our Sponsors

Go to Top